FDA Orders Blindness Risk Warning on Wegovy and Ozempic

RecentNews.uk

The US FDA ordered a blindness risk warning on popular weight loss and diabetes drugs.

Affected medications include widely used treatments like Ozempic and Wegovy.

The warning highlights a rare eye condition that can potentially lead to vision loss.

Patients are advised to speak with clinicians before making any changes to their medication.

Does this new regulatory warning change your view on using popular weight loss treatments?

Tap below to vote and see what others think.